Extended Research →
Verdict, decision matrix, deep dives, sourcing notes & full sources

Eleuthero (Siberian Ginseng)

Adaptogen from Northern Asia / Russian Far East — the original "Russian adaptogen" studied extensively in Soviet-era sport-medicine and military performance literature. | Compound

Aliases (5)
Siberian ginseng · Eleutherococcus senticosus · Ci Wu Jia · Touch-me-not · Devil's shrub
TYPICAL DOSE
300-600 mg standardized extract/day
ROUTE
CYCLE
STORAGE
Did you know? You can suggest edits to improve this compound's information.
Submitted via email — no account required.
Suggest an edit
Overview TL;DR

Adaptogen from Northern Asia / Russian Far East — the original "Russian adaptogen" studied extensively in Soviet-era sport-medicine and military performance literature. Not a true ginseng (different genus from Panax) — the "Siberian ginseng" name is a marketing artifact, not a botanical or pharmacological accuracy. Active constituents are eleutherosides B and E (lignan-related glycosides). Best-evidenced uses: stress resilience, mild immune support, fatigue resistance under physical load. For Dylan: OPTIONAL-ADD low priority; V4 rhodiola is the better-evidenced adaptogen for the same goals. Useful in immune-frequency-illness archetypes.

Mechanism of action

Eleutherococcus senticosus is a thorny shrub native to Northeast Asia. The roots and rhizomes contain eleutherosides A through M plus polysaccharides, lignans, and triterpenoid saponins. Standardized extracts target eleutheroside B + E content (typically ≥0.8%).

Mechanism dimensions:

1. HPA-axis modulation:

  • Eleutherosides modulate cortisol response to acute stress in animal models
  • Reduces ACTH and cortisol elevation in stress paradigms
  • Mechanism less crisply defined than rhodiola's monoamine angle — likely indirect via hippocampal glucocorticoid receptor sensitivity

2. Immune modulation:

  • Polysaccharides activate macrophages, NK cells, and T-cell populations in vitro and in vivo
  • Bohn 1987 (German trial) — eleuthero extract increased CD3+ and CD4+ lymphocytes in healthy volunteers
  • Mild signal for reducing common cold severity/duration in Russian/German trials

3. Cognitive endurance / fatigue:

  • Soviet sports-medicine literature (1960s-70s): improved physical work capacity, reduced perceived exertion
  • Not a stimulant — described as "fatigue ceiling raise" rather than "energy boost"
  • Mechanism likely indirect via stress smoothing rather than direct CNS effect

4. Mild anti-inflammatory + antioxidant:

  • Eleutherosides have modest free-radical scavenging activity
  • Reduces inflammatory marker elevations in animal stress models

5. Cardiovascular:

  • Mild vasodilation reported
  • Some Russian data on improved cardiovascular endurance in athletes

Pharmacokinetics: Eleutherosides have moderate oral bioavailability; effects typically build over 2-6 weeks of consistent dosing.

Pharmacokinetics No data
Pharmacokinetics data not available for this compound.
No half-life mentions found in the source notes.
What to expect Generic
  1. 1
    Week 1
    Tolerability and dose-response.
  2. 2
    Week 2-4
    Early effect window.
  3. 3
    Week 4-8
    Peak benefit assessment.
  4. 4
    Week 8+
    Cycle decision point.
Side effects + safety
  • Common (>10%): Mild GI upset, drowsiness in some users
  • Less common (1-10%): Mild headache, hypertension at high doses (sympathomimetic-like signal, less than Panax ginseng)
  • Rare-serious (<1%): Allergic reactions; theoretical hypoglycemia
  • Specific watch periods: Blood pressure if hypertension-prone
Interactions6 compounds
  • rhodiolaSynergistic
    (Dylan's V4): Both are classical Russian adaptogens; rhodiola is more stimulating, eleuthero more immune-skewed
  • schisandraSynergistic
    Russian "ADAPT-232" three-adaptogen combo
  • panax-ginsengSynergistic
    Compound adaptogen approach but increases stim-like signal
  • vitamin CSynergistic
    (Dylan's V4): Immune support compound stack
  • Other CNS stimulants at high dosesAvoid
    Mild additive sympathomimetic
  • Anticoagulants (warfarin)Avoid
    Theoretical interaction; case reports
References5 sources
Was this helpful?
Your feedback shapes what we research deeper.
Continue: Extended Research →
Our verdict, decision matrix, deep dives, controversies, sources